Eltrombopag is a thrombopoietin receptor agonist used to treat low platelet counts in conditions such as idiopathic thrombocytopenic purpura (ITP) and severe aplastic anemia. It works by stimulating megakaryocyte production in the bone marrow, increasing platelet counts. This medication is essential for preventing bleeding complications. In summary, Eltrombopag is effective in managing low platelet counts.
Eltrombopag activates the thrombopoietin receptor, promoting megakaryocyte proliferation and differentiation, leading to increased platelet production.





